We found a match
Your institution may have access to this item. Find your institution then sign in to continue.
- Title
A small interfering RNA targeting proteinase-activated receptor-2 is effective in suppression of tumor growth in a Panc1 xenograft model.
- Authors
Iwaki, Kentaro; Shibata, Kohei; Ohta, Masayuki; Endo, Yuichi; Uchida, Hiroki; Tominaga, Masayuki; Okunaga, Ryoki; Kai, Seiichiro; Kitano, Seigo
- Abstract
Proteinase-activated receptor-2 (PAR-2), which is a G protein-coupled receptor, is activated in inflammatory processes and cell proliferation. We previously demonstrated that an anti-PAR-2 antibody suppresses proliferation of human pancreatic cells in vitro. However, there have been no studies of PAR-2 signaling pathways in vivo. The aim of this study was to determine whether blockade of PAR-2 by RNA interference influences pancreatic tumor growth. We originally constructed small interfering RNAs (siRNAs) targeting human PAR-2, and performed cell proliferation assays of Panc1 human pancreatic cancer cell line with these siRNAs. Intratumoral treatment with these PAR-2 siRNAs and atelocollagen was also performed in a xenograft model with nude mice and Panc1 cells. siRNAs against human PAR-2 inhibited proliferation of Panc1 cells, whereas control scramble siRNAs had no effect on proliferation. The PAR-2 siRNAs dramatically suppressed tumor growth in the xenograft model. PAR-2-specific siRNA inhibited growth of human pancreatic cancer cells both in vitro and in vivo. Blockade of PAR-2 signaling by siRNA may be a novel strategy to treat pancreatic cancer. © 2007 Wiley-Liss, Inc.
- Publication
International Journal of Cancer, 2008, Vol 122, Issue 3, p658
- ISSN
0020-7136
- Publication type
Article
- DOI
10.1002/ijc.23123